• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CARISOPRODOL Drug Record

  • Summary
  • Interactions
  • Claims
  • CARISOPRODOL chembl:CHEMBL1233

    Alternate Names:

    CARISOPRODOL CIV
    NSC-172124
    SOMA
    CARISOMA
    RELA
    CARISOPRODOL
    CARISOPRODATE
    ISOBAMATE
    CARBAMIC ACID 2-ISOPROPYLCARBAMOYLOXYMETHYL-2-METHYL-PENTYL ESTER
    SOMA®
    2-METHYL-2-PROPYLTRIMETHYLENE CARBAMATE ISOPROPYLCARBAMATE
    2-METHYL-2-PROPYL-1,3-PROPANEDIOL CARBAMATE ISOPROPYLCARBAMATE
    ISOPROPYL MEPROBAMATE
    (+-)-2-METHYL-2-PROPYL-1,3-PROPANEDIOL CARBAMATE ISOPROPYLCARBAMATE
    (1-METHYLETHYL)CARBAMIC ACID 2-(((AMINOCARBONYL)OXY)METHYL)-2-METHYLPENTYL ESTER
    N-ISOPROPY-2-METHYL-2-PROPYL-1,3-PROPANEDIOL DICARBAMATE
    CARISOPRODOLUM
    ISOPROPYLMEPROBAMATE
    (RS)-2-{[(AMINOCARBONYL)OXY]METHYL}-2-METHYLPENTYL ISOPROPYLCARBAMATE
    SOMEPROBAMATE
    ISOMEPROBAMATE
    chembl:CHEMBL1233
    pubchem.compound:2576
    chemidplus:78-44-4
    drugbank:00395
    rxcui:2101

    Drug Info:

    Drug Type small molecule
    Drug Groups approved
    Drug Categories carbamates
    Drug Categories carbamic acid esters
    Drug Categories central nervous system agents
    Drug Categories central nervous system depressants
    Drug Categories centrally-mediated muscle relaxation
    Drug Categories cytochrome p-450 cyp2c19 substrates
    Drug Categories cytochrome p-450 substrates
    Drug Categories muscle relaxants
    Drug Categories muscle relaxants, centrally acting agents
    Drug Categories musculo-skeletal system
    (0 More Sources)

    Publications:

    Kumar M et al., 2017, A Single Amino Acid Residue at Transmembrane Domain 4 of the <i>α</i> Subunit Influences Carisoprodol Direct Gating Efficacy at GABA<sub>A</sub> Receptors., J Pharmacol Exp Ther
    Kumar M et al., 2016, Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors., Eur J Pharmacol
    Gonzalez LA et al., 2009, Abuse Potential of Soma: the GABA(A) Receptor as a Target., Mol Cell Pharmacol
    Gonzalez et al., 2009, Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies., J. Pharmacol. Exp. Ther.
  • CARISOPRODOL   GABRG2

    Interaction Score: 0.46

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20419052 28642232 19244096


    Sources:
    DrugBank

  • CARISOPRODOL   GABRB2

    Interaction Score: 0.45

    Interaction Types & Directionality:
    modulator

    Interaction Info:

    PMIDs:
    20419052 26872987 19244096


    Sources:
    DrugBank

  • CARISOPRODOL   GABRA3

    Interaction Score: 0.27

    Interaction Types & Directionality:
    modulator

    Interaction Info:

    PMIDs:
    28642232 26872987


    Sources:
    DrugBank

  • CARISOPRODOL   GABRA1

    Interaction Score: 0.25

    Interaction Types & Directionality:
    activator (activating)
    modulator

    Interaction Info:

    PMIDs:
    20419052 26872987 19244096


    Sources:
    DrugBank

  • CARISOPRODOL   GABRA5

    Interaction Score: 0.19

    Interaction Types & Directionality:
    modulator

    Interaction Info:

    PMIDs:
    26872987


    Sources:
    DrugBank

  • CARISOPRODOL   CBX1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CARISOPRODOL   CYP2C19

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    FDA

  • DrugBank: DB00395

    • Version: 5.1.7

    Alternate Names:
    CARISOPRODOL DrugBank Drug Name
    78-44-4 CAS Number
    CARISOPRODOL Immediate release Drug Brand

    Drug Info:
    Drug Type small molecule
    Drug Groups approved
    Drug Categories carbamates

    Publications:
    Kumar M et al., 2017, A Single Amino Acid Residue at Transmembrane Domain 4 of the <i>α</i> Subunit Influences Carisoprodol Direct Gating Efficacy at GABA<sub>A</sub> Receptors., J Pharmacol Exp Ther
    Kumar M et al., 2016, Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors., Eur J Pharmacol
    Gonzalez LA et al., 2009, Abuse Potential of Soma: the GABA(A) Receptor as a Target., Mol Cell Pharmacol

  • DTC: CARISOPRODOL

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1233 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1233

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • FDA: Carisoprodol

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2021-04-13